AI Content Marketing for Fractional CMOs in Biotech & Pharma

The challenge: Content Marketing for Fractional CMOs in Biotech & Pharma

A fractional CMO juggles 2–5 clients at once — each with its own brand voice, channels, and KPIs. The bottleneck is execution bandwidth, not strategic clarity. Every hour spent on production is an hour not spent on strategy.

In Biotech & Pharma specifically, Fractional CMOs face a compounded constraint: Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch. FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute On Content Marketing, that means Ingest content briefs from SEO Agent and convert them into full draft articles; Score each draft against readability, brand voice, E-E-A-T signals, and keyword density targets — all needing consistent execution a stretched a fractional CMO can rarely sustain by hand.

How Hadrian's Content Marketing Agent works for Fractional CMOs in Biotech & Pharma

AI drafts, scores, and schedules content 10x faster than a human team, enabling consistent publishing cadence without agency spend. For a fractional CMO in Biotech & Pharma, the Content Marketing Agent reads SEO Agent brief queue (topics, target keywords, comp examples), GA4 (page views, time-on-page, scroll depth, conversion rate by post), CMS draft history (Contentful / Sanity / WordPress) and runs: Ingest content briefs from SEO Agent and convert them into full draft articles; Score each draft against readability, brand voice, E-E-A-T signals, and keyword density targets; Repurpose long-form posts into derivative assets: social snippets, email teasers, LinkedIn carousels; Manage editorial calendar: assign slots, track drafts-in-progress, flag overdue pieces; Run a freshness audit and queue evergreen posts for refresh when traffic declines >20%; A/B test headlines and meta descriptions, report winner lift — continuously, tuned to Biotech & Pharma buyers (VP Commercial Marketing at mid-size pharma; Director of Marketing Excellence at specialty biotech; Head of Omnichannel at large pharma) and Biotech & Pharma's channels: HCP email, med-ed portals, LinkedIn, congresses/events, speaker programs, rep-triggered digital, patient advocacy partnerships.

For Fractional CMOs that means Content Marketing execution running in the background — producing Published blog posts, landing pages, and pillar pages, Content calendar (30-day rolling, Notion or Airtable), Derivative asset pack per hero post (social, email, LinkedIn) — without manual triggering, under your approval gate before anything publishes or spends. Scale your fractional practice without scaling your hours.

What Fractional CMOs in Biotech & Pharma get

Outputs: Published blog posts, landing pages, and pillar pages, Content calendar (30-day rolling, Notion or Airtable), Derivative asset pack per hero post (social, email, LinkedIn), Monthly content performance scorecard. These move Content-attributed organic traffic (sessions/month), Lead-gen conversions from content (form fills, demo requests), Content freshness ratio (% posts updated in last 6 months) — the metrics Fractional CMOs in Biotech & Pharma are accountable for. The Content Marketing Agent coordinates with Hadrian's other agents so Content Marketing stays aligned with the rest of your Biotech & Pharma marketing operation.

RELATED